Bloomberg: Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

Oramed Pharmaceuticals won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa. “Oravax’s oral Covid-19 vaccine candidate could offer an exciting potential solution to the Covid pandemic and would eliminate several barriers to rapid, wide-scale distribution, potentially enabling people to administer the vaccine themselves at home,” said Oramed CEO Nadav Kidron. Read more here.

You may also be interested

Join our mailing list

Skip to content